GeoVax Labs

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GeoVax Labs and other ETFs, options, and stocks.

About GOVX

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. 

CEO
David A. Dodd
CEODavid A. Dodd
Employees
19
Employees19
Headquarters
Smyrna, Georgia
HeadquartersSmyrna, Georgia
Founded
1988
Founded1988
Employees
19
Employees19

GOVX Key Statistics

Market cap
9.20M
Market cap9.20M
Price-Earnings ratio
-0.16
Price-Earnings ratio-0.16
Dividend yield
Dividend yield
Average volume
28.37M
Average volume28.37M
High today
$3.21
High today$3.21
Low today
$2.59
Low today$2.59
Open price
$2.85
Open price$2.85
Volume
2.24M
Volume2.24M
52 Week high
$34.75
52 Week high$34.75
52 Week low
$0.9631
52 Week low$0.9631

Stock Snapshot

GeoVax Labs(GOVX) stock is priced at $2.65, giving the company a market capitalization of 9.2M. It carries a P/E multiple of -0.16.

On 2026-05-27, GeoVax Labs(GOVX) stock moved within a range of $2.59 to $3.21. With shares now at $2.65, the stock is trading +2.3% above its intraday low and -17.5% below the session's peak.

Trading activity shows a volume of 2.24M, compared to an average daily volume of 28.37M.

The stock's 52-week range extends from a low of $0.96 to a high of $34.75.

The stock's 52-week range extends from a low of $0.96 to a high of $34.75.

GOVX News

TipRanks 1d
GeoVax Labs discontinues development of COVID-19 vaccine candidate

GeoVax Labs (GOVX) announced earlier today a strategic prioritization of its development portfolio to concentrate resources on its lead programs, GEO-MVA and Ge...

Benzinga 5d
Geovax Labs Analyst Ratings and Price Targets | NASDAQ:GOVX - Benzinga

...

Geovax Labs Analyst Ratings and Price Targets | NASDAQ:GOVX - Benzinga
Benzinga 7d
GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats

• Geovax Labs stock is charging ahead with explosive momentum. Why are GOVX shares rallying? Ebola Outbreak Highlights Vaccine Demand GeoVax highlighted the Wor...

GeoVax Stock Higher As Company Highlights MVA Platform For Ebola Threats

People also own

Based on the portfolios of people who own GOVX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.